Grant: Planning Grants
University of British Columbia
$25,000.00
Canadian Biliary Atresia Registry Planning Meeting
EF 2012-13
Résumé
Biliary atresia is the most important pediatric liver disease. While a rare condition (1:19,000 live births in Canada), biliary atresia is the leading cause of liver failure in the pediatric population and the most common reason why children require a liver transplant. Early disease recognition and treatment, in the first months of life, is key for optimal survival and best outcomes. Yet previous research in Canada has identified delayed referral, untimely intervention and a lack of standardization of care as problematic. There is need for a national collaborative approach to BA health care delivery, education and research so as to improve the outcomes for the 300-400 affected Canadian children.
This application is to support a one day planning meeting that will bring together an expert team of pediatric liver specialists and pediatric surgeons from every pediatric university hospital center across Canada as well as citizens who have a vested interest in biliary atresia including family members of affected children and other volunteer organizations, to finalize the plans for and implement a Canadian biliary atresia registry (CBAR). The overall goal of CBAR is to generate evidence-based data to optimize standards of BA care in Canada and improve outcomes, and to provide a national collaborative platform for biliary atresia research, education and knowledge translation.
Programme
Planning Grants
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
282819
Name
Schreiber Richard A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Clinical
Prcname2
Planning Grants
Projecttitle
Canadian Biliary Atresia Registry Planning Meeting
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Planning Grants
Keyworddelim
Biliary Atresia; Biliary Atresia Registry; Evidence Based Research; Hepato-Portoenterostomy; Neonatal Cholestasis; Pediatric Liver Disease; Pediatric Liver Transplant
Abstract
Biliary atresia is the most important pediatric liver disease. While a rare condition (1:19,000 live births in Canada), biliary atresia is the leading cause of liver failure in the pediatric population and the most common reason why children require a liver transplant. Early disease recognition and treatment, in the first months of life, is key for optimal survival and best outcomes. Yet previous research in Canada has identified delayed referral, untimely intervention and a lack of standardization of care as problematic. There is need for a national collaborative approach to BA health care delivery, education and research so as to improve the outcomes for the 300-400 affected Canadian children.
This application is to support a one day planning meeting that will bring together an expert team of pediatric liver specialists and pediatric surgeons from every pediatric university hospital center across Canada as well as citizens who have a vested interest in biliary atresia including family members of affected children and other volunteer organizations, to finalize the plans for and implement a Canadian biliary atresia registry (CBAR). The overall goal of CBAR is to generate evidence-based data to optimize standards of BA care in Canada and improve outcomes, and to provide a national collaborative platform for biliary atresia research, education and knowledge translation.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Schreiber, Richard A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $25,000~ $0~